(Q36204781)

12 August 2017

Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis (English)

1 reference

pulmonary alveolar proteinosis

12 August 2017

1 reference

1 reference

1 reference

4

Barbara P Barna

1 reference

12 August 2017

7

Mary Jane Thomassen

1 reference

12 August 2017

Anagha Malur

1

1 reference

12 August 2017

Mani S Kavuru

2

1 reference

12 August 2017

Irene Marshall

3

1 reference

12 August 2017

Isham Huizar

5

1 reference

12 August 2017

Reema Karnekar

6

1 reference

12 August 2017

14 June 2012

1 reference

12 August 2017

1 reference

12 August 2017

13

1 reference

12 August 2017

46

1 reference

https://scigraph.springernature.com/pub.10.1186/1465-9921-13-46

12 August 2017

0 references

cites work

An open-label trial of rituximab therapy in pulmonary alveolar proteinosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Lysosomal phospholipase A2 is selectively expressed in alveolar macrophages

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Induction of lysosomal phospholipase A2 through the retinoid X receptor in THP-1 cells

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

B cell depletion therapy in systemic lupus erythematosus

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis

2 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-13-46

ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-13-46

Lentivirus-ABCG1 instillation reduces lipid accumulation and improves lung compliance in GM-CSF knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-13-46

Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-13-46

ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-13-46

Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432632

Serological diagnosis of idiopathic pulmonary alveolar proteinosis

22 September 2018

1 reference

12 December 2020

Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis

1 reference

12 December 2020

Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis

1 reference

12 December 2020

Restoration of PPARγ reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice

1 reference

12 December 2020

Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-13-46

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

22697800

1 reference